Aller au contenu principal
Profil bibliographique

Jon F. Moran

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

41Publications signalées
1371Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Lung Cancer Diagnosis and TreatmentLung Cancer Treatments and MutationsRespiratory Support and MechanismsGastric Cancer Management and OutcomesHepatocellular Carcinoma Treatment and Prognosis

Les publications récentes

2014 conference-abstract OpenAlex

ERCC-1 high-stage IIb/III esophageal cancer treated with nonplatinum-based neoadjuvant or definitive chemoradiotherapy.

Sulochana Devi Cherukuri, Paul R. Walker, Teresa Parent, Sharon Ben-Or et autres

e15047 Background: Optimal curative outcomes in esophageal cancer are achieved with tri-modality therapy of neoadjuvant chemoradiotherapy (CRT) followed by surgery; if not a surgical candidate, definitive CRT. A platinum agent is the standard of care in esophageal cancer CRT. ERCC-1 is a …

us (code pays fourni par la source)

0 citations Journal of Clinical Oncology
2012 conference-abstract OpenAlex

Surgical pathology findings of neoadjuvant full-dose irinotecan and cisplatin (IP) with concurrent thoracic radiation therapy (C-TRT) in stage III non-small cell lung cancer (NSCLC).

Paul R. Walker, Sharon Ben-Or, Jon F. Moran, Richard Fred Williams et autres

e17550 Background: Neoadjuvant C-TRT in stage IIIA NSCLC has become a standard of care. C-TRT sterilizes N2 nodes far better than primary tumors. TRT dose does seem to make a difference. In Intergroup 0139 with 45 Gy pre-op TRT, ypT0N0 was 18% …

us (code pays fourni par la source)

0 citations Journal of Clinical Oncology
2008 article OpenAlex

In the Beginning: Fundamentalism, the Scopes Trial, and the Making of the Antievolution Movement. By Michael Lienesch

Jon F. Moran

By now, scholarly studies of the Scopes trial seem to be approaching or exceeding the word count of “300 volumes of 3000 words apiece” that journalists were supposed to have filed from Dayton, TN, in July, 1925. Historians have approached the trial …

us (code pays fourni par la source)

0 citations Journal of the American Academy of Religion
2004 conference-abstract OpenAlex

Induction chemotherapy using paclitaxel and carboplatin and thoracic radiation prior to surgery for locoregionally advanced non-small cell lung cancer: Results of a phase II trial

James M. Leonardo, Jon F. Moran, Laurie Bullock, K. Sarma et autres

7301 Background: Surgery with complete resection of disease remains the optimal treatment for non-small cell lung cancer. We initiated a Phase II study to determine if patients with marginally resectable or potentially, but initially unresectable disease could be “downstaged” and eventually undergo …

us (code pays fourni par la source)

1 citation Journal of Clinical Oncology
2004 conference-abstract OpenAlex

Induction chemotherapy using paclitaxel and carboplatin and thoracic radiation prior to surgery for locoregionally advanced non-small cell lung cancer: Results of a phase II trial

James M. Leonardo, Jon F. Moran, Laurie Bullock, K. Sarma et autres

7301 Background: Surgery with complete resection of disease remains the optimal treatment for non-small cell lung cancer. We initiated a Phase II study to determine if patients with marginally resectable or potentially, but initially unresectable disease could be “downstaged” and eventually undergo …

us (code pays fourni par la source)

1 citation Journal of Clinical Oncology
2002 article OpenAlex

Preoperative Chemotherapy and Radiation for Advanced Esophageal Carcinoma

Nam Phong Nguyen, James M. Leonardo, Ulf Lennart Karlsson, Mohammad Salehpour et autres

The purpose of this study was to determine the toxicity and efficacy of single daily fractionation as compared with twice-a-day radiation therapy in combination with chemotherapy for preoperative locally advanced thoracic esophageal carcinoma. A retrospective survey was done of 42 patients undergoing …

us (code pays fourni par la source)

5 citations American Journal of Clinical Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.